Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -10,754 | N/A | N/A | N/A |
| Depreciation Amortization | 751 | N/A | N/A | N/A |
| Accounts receivable | -276 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 548 | N/A | N/A | N/A |
| Other Working Capital | 2,532 | N/A | N/A | N/A |
| Other Operating Activity | 1,859 | 0 | 0 | 0 |
| Operating Cash Flow | $-5,341 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -176 | N/A | N/A | N/A |
| Net Acquisitions | 250 | N/A | N/A | N/A |
| Other Investing Activity | 12 | 0 | 0 | 0 |
| Investing Cash Flow | $86 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 3,760 | N/A | N/A | N/A |
| Debt Repayment | -29 | N/A | N/A | N/A |
| Common Stock Issued | 1,249 | N/A | N/A | N/A |
| Other Financing Activity | -510 | 0 | 0 | 0 |
| Financing Cash Flow | $4,469 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,255 | N/A | N/A | N/A |
| End Cash Position | 469 | N/A | N/A | N/A |
| Net Cash Flow | $-785 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -5,341 | N/A | N/A | N/A |
| Capital Expenditure | -176 | N/A | N/A | N/A |
| Free Cash Flow | -5,516 | 0 | 0 | 0 |